
Our gene therapies are designed to halt or reverse progression of lysosomal disorders with a single infusion. Learn about us, our focus and technology, sign up for updates, and read articles to expand your gene therapy knowledge.
Location: United States, Massachusetts, Boston
Member count: 51-200
Total raised: $85M
Founded date: 2015
Founders name: Chris Mason
Founders Related Locations: Cambridge, MA, USA
Investors 3
Funding Rounds 2
Date | Series | Amount | Investors | Deal News |
01.02.2018 | Series B | $60M | - | aislingcap... |
02.08.2016 | Series A | $25M | - | fiercebiot... |
Mentions in press and media 15
Date | Title | Description | Category | Author | Source |
05.02.2018 | Capitalizi... | Announced Thursday, the raise ... | - | - | medcitynew... |
02.02.2018 | Term Sheet... | IPO DELAYS Good morning, Term... | - | - | fortune.co... |
01.02.2018 | Avrobio Ra... | Avrobio, a Cambridge, Mass.-ba... | USA | - | finsmes.co... |
01.02.2018 | AVROBIO, I... | CAMBRIDGE, Mass.–(BUSINESS WIR... | - | - | aislingcap... |
01.02.2018 | AVROBIO Re... | CAMBRIDGE, MA, AVROBIO annou... | - | - | vcnewsdail... |
01.02.2018 | AVROBIO, I... | Company to initiate Phase 2 tr... | - | - | svhealthin... |
01.02.2018 | AVROBIO Ra... | AVROBIO, Inc., a clinical-stag... | - | - | citybizlis... |
01.02.2018 | Avrobio pu... | Avrobio has raised $60 million... | Biotech | - | fiercebiot... |
02.08.2016 | Avrobio Ra... | Avrobio, Inc., a Cambridge, MA... | USA | - | finsmes.co... |
02.08.2016 | AVROBIO Ra... | CAMBRIDGE, Mass.--(BUSINESS WI... | - | - | citybizlis... |
Show more